Cost-effectiveness analysis of intradermal versus classical intramuscular COVID-19 vaccine administration

Authors

DOI:

https://doi.org/10.3329/bjp.v17i1.57593

Keywords:

Cost-effectiveness, COVID-19 , Vaccine

Abstract

n/a

Downloads

Download data is not yet available.
Abstract
21
Download
27

Author Biographies

Pathum Sookaromdee, Private Academic Consultant Center, Bangkok, Thailand.

Private Consultant

Viroj Wiwanitkit, Department of Community Medicine, Dr. D. Y. Patil University, Pune, India.

Honorary Professor

References

Hsia W. Emerging new coronavirus infection in Wuhan, China: Situation in early 2020. Case Study Case Rep. 2020; 10: 8-9.

Intapiboon P, Seepathomnarong P, Ongarj J, Surasombatpattana S, Uppanisakorn S, Mahasirimongkol S, Sawaengdee W, Phumiamorn S, Sapsutthipas S, Sangsupawanich P, Chusri S, Pinpathomrat N. Immunogenicity and safety of an intradermal BNT162b2 mRNA vaccine booster after two doses of inactivated SARS-CoV-2 vaccine in healthy population. Vaccines (Basel) 2021. 9: 1375.

Karim SA. COVID‑19 vaccine affordability and accessibility. Lancet 2020; 396: 238.

Schnyder JL, de Jong HK, Grobusch MP. Intradermal immunization: A dose-sparing strategy to combat global shortages of severe acute respiratory syndrome coronavirus 2 vaccines? Clin Microbiol Infect. 2022; 28: 6-8.

Schweiger M. Intradermal covid-19 vaccination could solve supply problems. BMJ. 2021; 374: 1980.

Wang J, Peng Y, Xu H, Cui Z, Williams RO 3rd. The COVID-19 vaccine race: Challenges and opportunities in vaccine formulation. AAPS Pharm Sci Tech. 2020; 21: 225.

Downloads

Published

2022-03-17

How to Cite

Sookaromdee, P., and V. . Wiwanitkit. “Cost-Effectiveness Analysis of Intradermal Versus Classical Intramuscular COVID-19 Vaccine Administration”. Bangladesh Journal of Pharmacology, vol. 17, no. 1, Mar. 2022, pp. 9-10, doi:10.3329/bjp.v17i1.57593.

Issue

Vol. 17 No. 1 (2022)

Section

Letter to the Editor

License

Copyright (c) 2022 Pathum Sookaromdee, Viroj Wiwanitkit

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).